Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Net Short-Term Debt Issued (Repaid) (2025)

Updated

Vitaspring Biomedical's Current Debt was $15.00 in fiscal Q1 2026 (quarter ended Apr 30, 2025).

Analysis

Vitaspring Biomedical (VSBC) Net Short-Term Debt Issued (Repaid) (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -499.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 15.00
API Access

Vitaspring Biomedical Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=VSBC&period=max&api_key=YOUR_API_KEY